RISE BIO TOP10 ACTIVERISE BIO TOP10 ACTIVERISE BIO TOP10 ACTIVE

RISE BIO TOP10 ACTIVE

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪113.28 M‬KRW
Fund flows (1Y)
‪21.17 M‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
1.4%
Shares outstanding
‪10.50 K‬
Expense ratio

About RISE BIO TOP10 ACTIVE


Issuer
KB Financial Group, Inc.
Brand
KB RISE
Inception date
Dec 24, 2024
Structure
Open-Ended Fund
Index tracked
KRX Bio Top 10 Index - KRW - Benchmark TR Gross
Management style
Passive
Primary advisor
KB Asset Management Co. Ltd.
ISIN
KR70000Z0003

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Geography
South Korea
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of February 20, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.92%
Health Technology96.59%
Technology Services3.34%
Bonds, Cash & Other0.08%
Cash0.08%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows